Waterford Panadol maker valued at €36bn in spin off

The consumer health business demerged from drug giant GSK as part of its move to trade independently and is also expected to commence trading on the New York Stock Exchange (NYSE) at market open on 22 July.

Dave Barrett, Country Manager, Haleon Ireland. Picture: Karen Dempsey

Shares in painkiller Panadol and Sensodyne toothpaste maker Haleon started trading on Monday, making the company the biggest European listing on the London Stock Exchange in over a decade.

Haleon runs one of its biggest manufacturing sites out of Dungarvan in Waterford, where it produces approximately nine billion Panadol tablets each year and employs 900 people.